PHARMACOKINETICS AND PROTEIN-BINDING OF HIGH-DOSE ETOPOSIDE

被引：0
|
作者：
SCHWINGHAMMER, TL
FLEMING, RA
ROSENFELD, CS
SHADDUCK, RK
STEWART, CF
机构：
[1] UNIV PITTSBURGH,PITTSBURGH,PA 15260
[2] UNIV TENNESSEE,CTR HLTH SCI,MEMPHIS,TN 38163
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1991年 / 49卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE
    NEWMAN, EM
    DOROSHOW, JH
    FORMAN, SJ
    BLUME, KG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 561 - 564
  • [2] THE PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE ETOPOSIDE
    CUNNINGHAM, D
    CUMMINGS, J
    BLACKIE, RB
    MCTAGGART, L
    BANHAM, SW
    KAYE, SB
    SOUKOP, M
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (02): : 117 - 123
  • [3] Pharmacokinetics of etoposide following administration of high-dose etoposide and etoposide phosphate
    Reif, S
    Grimm, J
    Kingreen, D
    Siegert, W
    Schunack, W
    Jaehde, U
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (03) : 156 - 157
  • [4] SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF HIGH-DOSE ETOPOSIDE
    SCHWINGHAMMER, TL
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) : 2768 - 2768
  • [5] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE (VP 16-213)
    HOLTHUIS, JJM
    POSTMUS, PE
    VANOORT, WJ
    HULSHOFF, B
    VERLEUN, H
    SLEIJFER, DT
    MULDER, NH
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (10): : 1149 - 1155
  • [6] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE AFTER SHORT-TERM INFUSION
    KOHL, P
    KOPPLER, H
    SCHMIDT, L
    FRITSCH, HW
    HOLZ, J
    PFLUGER, KH
    JUNGCLAS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (04) : 316 - 320
  • [7] ALTERED PROTEIN-BINDING OF ETOPOSIDE IN PATIENTS WITH CANCER
    STEWART, CF
    PIEPER, JA
    ARBUCK, SG
    EVANS, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) : 49 - 55
  • [8] ETOPOSIDE PROTEIN-BINDING IN CANCER-PATIENTS
    LIU, B
    EARL, HM
    POOLE, CJ
    DUNN, J
    KERR, DJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (06) : 506 - 512
  • [9] UNALTERED PHARMACOKINETICS AFTER THE ADMINISTRATION OF HIGH-DOSE ETOPOSIDE WITHOUT PRIOR DILUTION
    EHNINGER, G
    PROKSCH, B
    SCHMIDT, H
    WAIDELICH, P
    EICHEL, B
    DOPFER, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (03) : 214 - 216
  • [10] Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens
    Würthwein, G
    Klingebiel, T
    Krümpelmann, S
    Metz, M
    Schwenker, K
    Kranz, K
    Lanvers, C
    Boos, J
    ANTI-CANCER DRUGS, 2002, 13 (01) : 101 - 110
12345